Ghrelin-attenuated cognitive dysfunction in streptozotocin-induced diabetic rats

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 4, 2011, Pages 352-363

  Ma, Lou Yan ^a   Zhang, Dong Min ^a   Tang, Yong ^a   Lu, Yang ^a   Zhang, Yin ^a   Gao, Yuan ^a   Xia, Li ^a   Zhao, Ke Xiang ^a   Chai, Li Yin ^a   Xiao, Qian ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; BDNF; cognitive function; CREB; Diabetic encephalopathy; ERK1 2

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXTRO LYSINE 3 GROWTH HORMONE SECRETAGOGUE RECEPTOR 6; GHRELIN; GHRELIN RECEPTOR; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL XL; PROTEIN INHIBITOR; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETIC ENCEPHALOPATHY; DRUG EFFECT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MAZE TEST; MEMORY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OPEN FIELD TEST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; STREPTOZOCIN DIABETES; TREATMENT RESPONSE;

ANIMALS; APOPTOSIS; COGNITION DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; GHRELIN; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 81855194326     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31820ce536     Document Type: Article

References (48)

1. Biessels GJ, Heide LP, Kamal A, et al. Ageing and diabetes: implications for brain function. Eur J Pharmacol. 2002;441: 1-14. (Pubitemid 34465684)
2. Allen KV, Frier BM, Strachan MWJ. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004; 490:169-175. (Pubitemid 38482170)
3. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5:64-74. (Pubitemid 41790697)
4. Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. J Trends Neurosci. 2000;23:542-549.
5. Manschot SM, Brands AM, vander Groud J, et al. Brain magnetic Resona-Nce imaging correlates ofimpaired cognition in patients with type2 diabetes. Diabetes. 2006;55:1106-1113. (Pubitemid 44100188)
6. Ott A, Stolk RP, Hofman A, et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia. 1996;39:1392-1397. (Pubitemid 26356072)
7. Moroc N, Tong M, Longato L, et al. Limited Alzheimer type neurodegeneration in experimental obesity and type 2 diabetes mellitus. JAlzheimer Dis. 2008;15:29-44.
8. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm. 2002;109:341-360. (Pubitemid 34251638)
9. Steen E, Terry BM, Rivera EJ, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease- is this type 3 diabetes? J Alzheimer Dis. 2005;7:63-80. (Pubitemid 40387185)
10. Dai J, Vrensen GF, Schlinqemann RO. Blood\-brain barrier integrity is unaltered in human brain cortex with diabetes mellitus. Brain Res. 2002;954:311-316. (Pubitemid 35284672)
11. Kamal A, Ramakers GM, Biessels GJ, et al. Effects of a phorbol ester and cyclosporin A on hippocampal synaptic plasticity in streptozotocin-induced diabetic rats: reduced sensitivity to phorbol esters. Neurosci Lett. 2003;339:45-48. (Pubitemid 36263217)
12. Dornonville de la Cour C, Bjorkqvist M, Sandvik AK, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept. 2001;99:141-150. (Pubitemid 32522540)
13. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660. (Pubitemid 129516334)
14. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation offeeding. Nature. 2001;409:194-198. (Pubitemid 32144284)
15. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522. (Pubitemid 40404635)
16. Van der Lely AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological as-pects ofghrelin. Endocr Rev. 2004;25:426-457.
17. Ghigo E, Broglio F, Arvat E, et al. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf). 2005;62:1-17. (Pubitemid 40175277)
18. Carlini VP, Varas MM, Caagnolini AB, et al. Differential role of the hippocampus, amy gala and dorsal raphe nucleus in regulating feeding, memory, and anxiety like behavioral responses to ghrelin. Biochem Res Commun. 2004;26:203-250.
19. Yokoyama T, Sato T, Ohbuchi T, et al. Ghrelin potentates miniature excitatory postsynaptic currents in supraoptic magnocellular neurons. Journal of Neuroendocrinology. 2009; 21:910-920.
20. Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006;9:381-388. (Pubitemid 43290968)
21. Zhang HN, Gao Y, Zhao KX, et al. Effects of Telmisartan on learning and memory and expression of ghrelin receptor in diabetic rats. Chin Hosp Pharm J. 2008;28:1832-1835.
22. Alvarez EO, Ruarte MB. Histaminergic neurons of the ventral hippocampus and the baso-lateral amygdale of the rat: functional interaction on memory and learning mechanisms. Behav Brain Res. 2002;128:81-90. (Pubitemid 34033637)
23. Biessels GJ, Kamal A, Ramakers GM, et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 1996;45:1259-1266. (Pubitemid 26296329)
24. Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory. Neurobiol Learn Memory. 2008;89:312-323. (Pubitemid 351318269)
25. Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15: 331-337.
26. Mu JS, Li WP, Yao ZB, et al. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res. 1999;835:259-265.
27. Siegel GJ, Chauhan NB. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Rev. 2000;33:199-227.
28. Zuccato C, Ciammola A, Rigamonti D, et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science. 2001;293:493-498. (Pubitemid 32679077)
29. Canals JM, Pineda JR, Torres-Peraza JF, et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degen-erationin Huntington's disease. J Neurosci. 2004;24:7727-7739. (Pubitemid 39186828)
30. Warburton EC, Glover CPJ, Massey PV, et al. CAMP responsive element-binding protein phosphorylation is neces-sary for peripheral long-term potentiation and recognition memory. J Neurosci. 2005;25:6296-6303. (Pubitemid 40962524)
31. Hong EJ, West AE, Greenberg ME. Transcriptional control of cognitive development. Curr Opin Neurobiol. 2005;15:21-28. (Pubitemid 40249957)
32. Chen L, Miyamoto Y, Furuya K, et al. PREGS induces LTP in the hippocampal dentate gyrus of adult rats via the tyrosine phosphorylation of NR2b coupled to ERK/CREB signaling. J Neurophysiology. 2007;98:1538-1548. (Pubitemid 47435900)
33. Meyer CJ, Alenghat FJ, Rim P, et al. Mechanical control of cyclic AMP signaling and gene transcription through integrins. Nature Cell Biol. 2000;2:666-668.
34. Hotte M, Thuault S, Dinely KT, et al. EB and DARPP-32 during late LTP at hippocampal to prefrontal cortex synapses in vivo. Synapse. 2007;61:24-28. (Pubitemid 44924655)
35. Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol. 2002;159:1029-1037. (Pubitemid 36055757)
36. Kim MS, Yoon CY, Jang PG, et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol. 2004;18:2291-2301.
37. Chung H, Kim E, Lee DH, et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose depriva-tion. Endocrinology. 2007;148:148-159. (Pubitemid 46021447)
38. Kim SW, Her SJ, Park SJ, et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone. 2005;37:359-369. (Pubitemid 41160494)
39. Marini AM, Jiang H. Hormesis: a promising strategy to sustain endogenous neuronal survival pathways against neurodegenerative disorders. Aging Res Rev. 2008;7:21-33.
40. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407:802-809.
41. Griesbach GS, Hovada A, Gomez-Pinilla F. Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res. 2009;1288:105-115.
42. Tanaka J, Horiike Y, Matsuzaki M, et al. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science. 2008;319:1683-1687. (Pubitemid 351432509)
43. Sairanen M, Lucas G, Ernfors P, et al. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci. 2005;25: 1089-1094. (Pubitemid 40268949)
44. Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem. 2002;82:1367-1375.
45. Rossi C, Angelucci A, Lostantin L, et al. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrich-ment. Eur J Neurosci. 2006;24:1850-1856. (Pubitemid 44583469)
46. Young D, Lawlor PA, Lenone P, et al. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med. 1999;5:448-453. (Pubitemid 29180587)
47. Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus. 2006;16:239-249.
48. Jiang Z, Zhang Y, Chen X, et al. Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun. 2002;294:726-733. (Pubitemid 34694073)